These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 24647047)
1. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis. Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047 [TBL] [Abstract][Full Text] [Related]
2. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies. Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573 [TBL] [Abstract][Full Text] [Related]
3. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis. Meng F; Song L; Wang W J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076 [No Abstract] [Full Text] [Related]
4. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences. Wang Y; Xiao J; Zhao Y; Du S; Du J Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113 [TBL] [Abstract][Full Text] [Related]
5. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis. Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371 [TBL] [Abstract][Full Text] [Related]
6. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus. Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114 [TBL] [Abstract][Full Text] [Related]
7. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis. He XK; Su TT; Si JM; Sun LM Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616 [TBL] [Abstract][Full Text] [Related]
8. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis. Nie Z; Zhu H; Gu M Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666 [TBL] [Abstract][Full Text] [Related]
9. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression. Ng CW; Jiang AA; Toh EMS; Ng CH; Ong ZH; Peng S; Tham HY; Sundar R; Chong CS; Khoo CM Int J Colorectal Dis; 2020 Aug; 35(8):1501-1512. PubMed ID: 32592092 [TBL] [Abstract][Full Text] [Related]
10. The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study. Chu PT; Chuang TJ; Huang SH; Wu TH; Huang WC; Wang JH J Int Med Res; 2023 Apr; 51(4):3000605231168033. PubMed ID: 37077173 [TBL] [Abstract][Full Text] [Related]
11. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients. Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714 [TBL] [Abstract][Full Text] [Related]
12. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis. Tian S; Lei HB; Liu YL; Chen Y; Dong WG Chronic Dis Transl Med; 2017 Sep; 3(3):169-175. PubMed ID: 29063073 [TBL] [Abstract][Full Text] [Related]
13. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer. Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094 [TBL] [Abstract][Full Text] [Related]
14. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes. Chen CH; Lin CL; Hsu CY; Kao CH QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243 [TBL] [Abstract][Full Text] [Related]
15. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer. Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948 [TBL] [Abstract][Full Text] [Related]
16. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523 [TBL] [Abstract][Full Text] [Related]
17. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis. Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955 [TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression. Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523 [TBL] [Abstract][Full Text] [Related]
19. Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis. Petrelli F; Ghidini M; Rausa E; Ghidini A; Cabiddu M; Borgonovo K; Ghilardi M; Parati MC; Pietrantonio F; Sganzerla P; Bossi AC Can J Diabetes; 2021 Mar; 45(2):186-197.e2. PubMed ID: 33039329 [TBL] [Abstract][Full Text] [Related]
20. Metformin and Colorectal Cancer - A Systematic Review. Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]